A highly accurate and selective non-enzymatic glucose sensor based on a Fe2O3/CuFe2O4/graphene nanoplatelet
Lilia Bourouba1,2,3, Emna Zouaoui3,4, Messaoud Benounis2
1Research Laboratory on Physical Chemistry of Surfaces and Interfaces (LRPCSI), Department of Process Engineering, Faculty of Technology, University of 20 August 1955 Skikda 21000 Algeria hendamer2000@yahoo.com l.bourouba@univ-skikda.dz.
Abstract:
In this study, a sensitive and accurate non-enzymatic glucose sensor based on a Fe2O3/CuFe2O4/graphene nanoplatelet (GNPs) nanocomposite was performed. The nanocomposite was synthesized via a facile hydrothermal method and characterized using FTIR, XRD, SEM, Raman, XPS, cyclic voltammetry (CV) and electrochemical impedance spectroscopy techniques. The integration of Fe2O3 and CuFe2O4 with graphene nanoplatelets (GNPs) provides a synergistic effect, enhanced surface area, high electrochemical conductivity and improved catalytic activity toward glucose oxidation. Electrochemical measurements using CV and chronoamperometry demonstrated excellent sensing performance, with high sensitivity of 62.4 μA mM-1 cm-2, a lower of detection limit of 0.049 μM (S/N = 3) and a widely linear detection range from 5-75 μM and 75-13 000 μM. The sensor exhibited outstanding selectivity against common interfering species (e.g., dopamine, uric acid and ascorbic acid), along with good stability and reproducibility. These findings suggest that the Fe2O3/CuFe2O4/GNPs nanocomposite is a promising applicant for glucose non-enzymatic sensing in clinical and biomedical applications.
More Related Videos
07:51Development and Functionalization of Electrolyte-Gated Graphene Field-Effect Transistor for Biomarker Detection
Published on: February 1, 2022
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Published on: March 31, 2022
